(6342) Intrasight Integ
Payments companies reported to CMS as associated with (6342) Intrasight Integ. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (6342) Intrasight Integ, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (6342) Intrasight Integ
These are the largest totals companies reported as associated with (6342) Intrasight Integ. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Karim Al-Azizi | Plano, TX | Interventional Cardiology | $452.08 |
| Jasvindar Singh | Saint Louis, MO | Interventional Cardiology | $283.13 |
| Darshan Doshi | Boston, MA | Interventional Cardiology | $254.67 |
| Nandish Thukral | San Antonio, TX | Interventional Cardiology | $243.24 |
| Salvatore Barbaro | San Antonio, TX | Interventional Cardiology | $228.75 |
| Bruce Samuels | Beverly Hills, CA | Cardiovascular Disease | $226.55 |
| Sridhar Sampath-Kumar | Aurora, CO | Interventional Cardiology | $211.54 |
| Philipp Wiesner | Springfield, MO | Interventional Cardiology | $193.64 |
| Samuel Lindner | Saint Louis, MO | Interventional Cardiology | $143.12 |
| Prashanth Thakker | Saint Louis, MO | Interventional Cardiology | $140.96 |
Prescribed (6342) Intrasight Integ?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.